1-20 of 49
Authors: Stefan Schreiber
Save search
Sort by
Journal Article

TREATMENT OF MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS WITH RO7790121 DEMONSTRATES EARLY CLINICAL RESPONSE AND SYMPTOM IMPROVEMENT – RESULTS FROM THE PHASE 2B TUSCANY-2 TRIAL

PDF
Jessica Allegretti and others
Inflammatory Bowel Diseases, Volume 31, Issue Supplement_1, February 2025, Page S12, https://doi.org/10.1093/ibd/izae282.028
Published: 28 February 2025
Journal Article

BASELINE PROGNOSTIC FACTORS OF BOWEL URGENCY IMPROVEMENT IN PATIENTS WITH ULCERATIVE COLITIS TREATED WITH MIRIKIZUMAB

PDF
Marla Dubinsky and others
Inflammatory Bowel Diseases, Volume 31, Issue Supplement_1, February 2025, Pages S62–S63, https://doi.org/10.1093/ibd/izae282.147
Published: 28 February 2025
Journal Article

TWO-YEAR RESULTS OF SUBCUTANEOUS INFLIXIMAB (CT-P13 SC) DOSE ESCALATION THERAPY - FROM LIBERTY-CD AND LIBERTY-UC

PDF
Stephen B Hanauer and others
Inflammatory Bowel Diseases, Volume 31, Issue Supplement_1, February 2025, Page S13, https://doi.org/10.1093/ibd/izae282.029
Published: 28 February 2025
Journal Article

PATIENT-REPORTED DISEASE CONTROL IN MODERATE-TO-SEVERE CROHN’S DISEASE AND ULCERATIVE COLITIS: RESULTS FROM THE COMMUNICATING NEEDS AND FEATURES OF IBD EXPERIENCES (CONFIDE) SURVEY

PDF
David Rubin and others
Inflammatory Bowel Diseases, Volume 31, Issue Supplement_1, February 2025, Pages S70–S71, https://doi.org/10.1093/ibd/izae282.163
Published: 28 February 2025
Journal Article

IMPACT OF IMMUNOGENICITY ON CLINICAL OUTCOMES IN PATIENTS WITH ULCERATIVE COLITIS RECEIVING MAINTENANCE TREATMENT WITH SUBCUTANEOUS INFLIXIMAB: A POST HOC ANALYSIS OF THE LIBERTY-UC STUDY

PDF
Jean-Frederic Colombel and others
Inflammatory Bowel Diseases, Volume 31, Issue Supplement_1, February 2025, Page S9, https://doi.org/10.1093/ibd/izae282.023
Published: 28 February 2025
Journal Article

CROHN’S DISEASE AND BOWEL URGENCY: US AND EUROPEAN PATIENT AND HEALTHCARE PROFESSIONAL PERSPECTIVES FROM THE COMMUNICATING NEEDS AND FEATURES OF IBD EXPERIENCES (CONFIDE) SURVEY

PDF
David Rubin and others
Inflammatory Bowel Diseases, Volume 31, Issue Supplement_1, February 2025, Pages S64–S65, https://doi.org/10.1093/ibd/izae282.150
Published: 28 February 2025
Journal Article

Health-Related Quality of Life Outcomes With Etrasimod Treatment in Patients With Ulcerative Colitis: A Post Hoc Analysis of Data From ELEVATE UC 52 and ELEVATE UC 12

PDF
Alessandro Armuzzi and others
Inflammatory Bowel Diseases, izae229, https://doi.org/10.1093/ibd/izae229
Published: 26 September 2024
Journal Article

Benefit-Risk Trade-offs and Patient Preferences for Therapy Selection in Ulcerative Colitis: a Multicountry Preference Study

PDF
Javier P Gisbert and others
Inflammatory Bowel Diseases, izae162, https://doi.org/10.1093/ibd/izae162
Published: 10 August 2024
Journal Article

COMPARATIVE EFFICACY AND SAFETY OF SUBCUTANEOUS INFLIXIMAB AND VEDOLIZUMAB MAINTENANCE THERAPY IN PATIENTS WITH CROHN’S DISEASE AND ULCERATIVE COLITIS: AN INDIRECT COMPARISON FROM RANDOMIZED CONTROLLED TRIALS

PDF
Bruce Sands and others
Inflammatory Bowel Diseases, Volume 30, Issue Supplement_1, February 2024, Pages S4–S5, https://doi.org/10.1093/ibd/izae020.011
Published: 25 January 2024
Journal Article

SUBCUTANEOUS INFLIXIMAB (CT-P13 SC) DOSE ESCALATION AS AN OPTION FOR MANAGING THE LOSS OF RESPONSE IN INFLAMMATORY BOWEL DISEASE POST HOC ANALYSIS OF LIBERTY-UC AND LIBERTY-CD STUDY

PDF
Silvio Danese and others
Inflammatory Bowel Diseases, Volume 30, Issue Supplement_1, February 2024, Page S00, https://doi.org/10.1093/ibd/izae020.022
Published: 25 January 2024
Journal Article

NETWORK META-ANALYSIS TO EVALUATE THE COMPARATIVE EFFICACY OF BIOLOGICS FOR MAINTENANCE TREATMENT OF ADULT PATIENTS WITH CROHN’S DISEASE

PDF
Stefan Schreiber and others
Inflammatory Bowel Diseases, Volume 30, Issue Supplement_1, February 2024, Page S7, https://doi.org/10.1093/ibd/izae020.016
Published: 25 January 2024
Journal Article

EFFICACY, SAFETY AND IMMUNOGENICITY OF SUBCUTANEOUS INFLIXIMAB (CT-P13 SC) MONOTHERAPY VERSUS COMBINATION THERAPY WITH IMMUNOSUPPRESSANTS – POST HOC ANALYSIS OF LIBERTY-CD AND LIBERTY-UC STUDY

PDF
Stefan Schreiber and others
Inflammatory Bowel Diseases, Volume 30, Issue Supplement_1, February 2024, Pages S8–S9, https://doi.org/10.1093/ibd/izae020.019
Published: 25 January 2024
Journal Article

The Communicating Needs and Features of IBD Experiences (CONFIDE) Study: US and European Patient and Health Care Professional Perceptions of the Experience and Impact of Symptoms of Moderate-to-Severe Ulcerative Colitis

PDF
Simon Travis and others
Inflammatory Bowel Diseases, Volume 30, Issue 6, June 2024, Pages 939–949, https://doi.org/10.1093/ibd/izad142
Published: 21 August 2023
Journal Article

Real-World Effectiveness of Vedolizumab vs Anti-TNF in Biologic-naïve Crohn’s Disease Patients: A 2-year Propensity-score-adjusted Analysis from the VEDOIBD-Study

PDF
Bernd Bokemeyer and others
Inflammatory Bowel Diseases, Volume 30, Issue 5, May 2024, Pages 746–756, https://doi.org/10.1093/ibd/izad138
Published: 31 July 2023
Journal Article

Real-world Comparative Effectiveness of Ustekinumab vs Anti-TNF in Crohn’s Disease With Propensity Score Adjustment: Induction Phase Results From the Prospective, Observational RUN-CD Study

PDF
Bernd Bokemeyer and others
Inflammatory Bowel Diseases, Volume 29, Issue 11, November 2023, Pages 1741–1750, https://doi.org/10.1093/ibd/izac271
Published: 12 January 2023
Journal Article

COMMUNICATING NEEDS AND FEATURES OF IBD EXPERIENCES (CONFIDE) SURVEY: BURDEN AND IMPACT OF BOWEL URGENCY ON PATIENTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS

PDF
Stefan Schreiber and others
Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Page S79, https://doi.org/10.1093/ibd/izac015.127
Published: 22 January 2022
Journal Article

Long-Term Safety and Efficacy of the Anti-Mucosal Addressin Cell Adhesion Molecule-1 Monoclonal Antibody Ontamalimab (SHP647) for the Treatment of Crohn’s Disease: The OPERA II Study

PDF
Geert R D’Haens and others
Inflammatory Bowel Diseases, Volume 28, Issue 7, July 2022, Pages 1034–1044, https://doi.org/10.1093/ibd/izab215
Published: 24 August 2021
Journal Article

Ulcerative Colitis Narrative Global Survey Findings: Communication Gaps and Agreements Between Patients and Physicians

PDF
David T Rubin and others
Inflammatory Bowel Diseases, Volume 27, Issue 7, July 2021, Pages 1096–1106, https://doi.org/10.1093/ibd/izaa257
Published: 15 October 2020
Journal Article

Clinical Practice of Adalimumab and Infliximab Biosimilar Treatment in Adult Patients With Crohn’s Disease

PDF
Walter Reinisch and others
Inflammatory Bowel Diseases, Volume 27, Issue 1, January 2021, Pages 106–122, https://doi.org/10.1093/ibd/izaa078
Published: 07 July 2020
Journal Article

Association of Biomarker Cutoffs and Endoscopic Outcomes in Crohn’s Disease: A Post Hoc Analysis From the CALM Study

PDF
Walter Reinisch and others
Inflammatory Bowel Diseases, Volume 26, Issue 10, October 2020, Pages 1562–1571, https://doi.org/10.1093/ibd/izaa025
Published: 27 February 2020